This section contains a list of Health Canada consultations that had been posted online while active and are now closed. Here you will find an archive of consultation information ranging from
initial calls for feedback to any available reports generated
by the consultation activity.
 A |
Addition
of Vitamins and Minerals Policy Review and Implementation
This document is designed to help you provide us with your
comments and, ultimately, influence the development of new
regulations on addition of vitamins and minerals to foods for
Canada.
Available Reports: Report
1, Report
2, Report
3
Assisted Human Reproduction Act -- Consultation with Counselling Professionals
The purpose of this workshop is to discuss proposed policy options for the regulation of AHR counselling services with AHR counselling professionals.
Second Round of External Stakeholder Consultations Revised Draft Consumer Advertising Guidelines for Marketed Health Products (for Nonprescription Drugs including Natural Health Products)
Further to the February 2005 consultations, Health Canada is pleased to share with stakeholders the revised draft Consumer Advertising Guidelines for Marketed Health Products (for Nonprescription Drugs including Natural Health Products (NHPs)). More ...
Invitational Roundtable -- Risk Information Communication (Section 2.21) of the Revised Draft Consumer Advertising Guidelines for Marketed Health Products
|
| B |
Public Forum
on Breast Implants
Health Canada is currently reviewing the license applications
of silicone gel-filled breast implants in Canada, with public
input being an integral part of the Department's decision-making
process. Health Canada has initiated a public forum to be held
September 29-30, 2005 as part of its process for assessing
the safety, risks, and benefits of silicone gel-filled breast
implants.
Expert Advisory Panel Report
|
| C |
Consultative
Committee for French-Speaking Minority Communities
This committee has ongoing meetings with Health Canada to assist and advise
the Minister of Health on issues relating to the Government of Canada's mandate
regarding health to develop French-speaking minority communities and foster
their growth.
Consultative Committee for English-Speaking Minority Communities
The main role of the Committee's is to assist and advise the
Minister of Health on issues relating to the Government of
Canada's mandate regarding health to develop English-speaking
minority communities and foster their growth.
Consultations
with Stakeholders on Phase Two of the Federal Tobacco Control Strategy
Health Canada's Tobacco Control Programme invites stakeholders engaged in tobacco control issues in Canada to share
their views concerning the second phase of the Federal Tobacco Control Strategy (FTCS). |
| D |
Development of Risk Management Strategy for Antimicrobial Resistance
-- Consultation with Stakeholders
Focus on the report of Health Canada Advisory Committee on
Animal Uses of Antimicrobials and Impact on Resistance and
Human Health.
Dietary
Guidance
To provide an update on proposed directions for national dietary
guidance such as Nutrition Recommendations for Canadians, Canada's
Guidelines for Healthy Eating and Canada's Food Guide to Healthy
Eating.
Draft Guidance for Industry on Management of Regulatory Submissions
The purpose of this document is to clarify the requirements
for key steps in the process and enable drug sponsors to improve
the quality of their submissions.
Draft Guidance for Industry on Preparation of Veterinary New Drug
Submissions
The purpose of this document is to provide guidance for the
preparation of a well-structured veterinary drug submission.
Draft Guidance
for Industry -- Pharmaceutical Quality of Inhalation and Nasal
Products
This document is intended to provide guidance to industry on
the pharmaceutical quality of inhalation and nasal products
to be authorized for marketing in Canada and/or in the European
Union.
|
| E |
Consultation
on proposed regulatory standards for e-prescribing in Canada
|
| F |
Federal-Provincial-Territorial
Committee on Drinking Water: Guideline Technical Document on Haloacetic Acids for public
comment
The purpose of this consultation is to solicit comments on a proposed guideline, on the approach used for its development
and on the potential economic costs of implementing it, as well as to determine the availability of additional
exposure data.
Framework for Collaborative Pan-Canadian Health Human Resources Planning
Thank you for your contribution to the stakeholder engagement process of the Framework for Collaborative Pan-Canadian Health Human Resources Planning. This engagement process officially closed March 31, 2006. We have received your input and will be using it to inform the next steps regarding the implementation of the Framework's Action Plan. We thank you for taking the time to submit this valuable input.
Online Consultation on Canada's Food Guide Revision
Thank you for participating in the consultation. The consultation closed on March 24, 2006 and responses are currently being analyzed. A summary of the analysis of responses will be posted on this site once available.
2002
Consultations on Food Directorate Priorities and Actions
Natural
Health Products Directorate (NHPD) Consultation on Fatty Acids
and Essential Fatty Acids (EFAs)
|
| G |
Guidelines
for Cosmetic Advertising and Labelling Claims
These guidelines are used extensively by both industry and
government officials to assess the acceptability of cosmetic
claims.
Guidelines for the Safety Assessment of Novel Foods Derived from Plants and Microorganisms
These guidelines define the criteria and basic information
requirements that must be considered in assessing the safety
of novel whole foods and food constituents.
|
| H |
Health
Canada's Food Directorate Regional Stakeholder Forum
in Vancouver
Gain a better understanding of priority food safety and nutrition
issues in the Western Region and what improvements may be
required to the regulatory framework to better address those
issues.
Health Canada
Reviews Schedule A to the Food and
Drugs Act
Available
Report
Health
Protection Legislation Renewal -- Veterinary Drugs Discussion
Document
A comprehensive review of the health protection system aimed
at replacing outdated federal statutes that were developed
decades ago in a piecemeal fashion.
Available
Report
|
| I |
Information sharing workshop on the licensing framework of the AHR Act
The purpose of this workshop is to obtain advice on issues and options related to the administration of licensing under the Act (sections 40, 41, and 42) and on information disclosure related to licensing and enforcement activities (section 19).
|
| L |
Labelling
of Unpasteurized Fruit Juice / Cider
Thank you for participating in the consultation. The session closed on December 16, 2005 and Health Canada is now analyzing the responses. A summary of the analysis will be posted in Spring 2006, along with the next steps.
|
| M |
Multi-stakeholder
Task Force on Trans Fat
Health Canada, in conjunction with the Heart and Stroke Foundation of Canada,
works through a multi-stakeholder task force to develop recommendations and strategies
for reducing trans fats in Canadian foods to the lowest level possible.
Measures
to help ensure Canadians' continued access to an adequate
supply of safe and affordable drugs (Internet Consultation)
Minister Dosanjh is reaffirming Health Canada's commitment
to the health and safety of Canadians and Canada's drug system
by proposing three measures to help protect Canada's drug
supply and enhance consumer safety.
Maximum
Residue Limits
Establishing
Maximum Residue Limits (MRLS) for Altrenogest
Ongoing consultations to obtain feedback from stakeholders
on proposed MRLs for Altrenogest. Feedback will be used for
the promulgation of MRLs.
MedEffect
Web site Consultations
To gather key stakeholder input for the development of the
MedEffect portal, which allows centralized access to new
safety information about marketed health products.
|
| N |
Natural Health Products Directorate (NHPD) Consultation on Fatty Acids and Essential Fatty Acids (EFAs)
In March 2005, the NHPD commissioned a discussion paper that
focused on Canadian fatty acid and EFA research and issues
related to conducting fatty acid and EFA research in Canada.
Following an extensive internet search and interviews with
key researchers, the need for more focused attention on EFAs
within the context of natural health products (NHPs) was identified,
most notably in the area of partnership building and dissemination
of information on the NHP Regulations and the Natural Health
Products Research Program (NHPRP).
|
| O |
Options
Analysis Paper will launch the stakeholder consultation
process to provide input on which of three regulatory
options and related arrangements stakeholders prefer
Options for the Registration and Disclosure of Clinical Trial Information of Health Products in Canada
Health Canada is working to develop a Canadian approach to the registration and disclosure of clinical trial information.
|
| P |
Proposed Amendments to the Hazardous Products (Matches) Regulations
Proposed Technical Amendments to Schedule I to the Hazardous Products Act, the Hazardous Products (Expansion Gates and Expandable Enclosures) Regulations and the Playpens Regulations
Consultations with Stakeholders on Phase Two of the Federal Tobacco Control Strategy
Request for comments on an issues paper regarding pre-implantation genetic diagnosis (PGD)
Proposal for Ceftiofur
Proposal for Danofloxacin
Proposal
for Diclazuril
Proposal
for Doramectin
Proposal
for Enrofloxacin
Proposal for Eprinomectin
Proposal
for Florfenicol
Proposal
for Flunixin
Proposal
for Ketoprofen (December 5, 2003)
Proposal
for Ketoprofen (January 24, 2005)
Proposal
for Lincomycin
Proposal
for Melengestrol Acetate (MGA)
Proposal
for Monensin
Proposal
for Narasin
Proposal
for Oxytetracycline
Proposal
for Pirlimycin
Proposal
for New Health-related Information on Tobacco Product
Labels
Consultation Paper
Proposed
Regulations Amending the Hazardous Products (Glazed
Ceramics and Glassware) Regulations
Stakeholder notification about proposed amendments
Public
Involvement Policy of the Veterinary Drugs Directorate
(VDD)
VDD's strategic objective is to create an open, transparent,
leading-edge, proactive organization that will enable its
stakeholders, partners and the public to understand and
contribute to VDD's priorities, capacity and performance
while also contributing to VDD's statutory responsibilities
as a regulator.
Proposal
on Integrated Framework for Health-Related Components
of CEPA DSL Categorization
To inform and obtain comment from stakeholder and general
public regarding proposal content and options listed leading
to an integrated Framework for Health-related Components
of DSL Categorization.
|
| R |
Radiological Characteristics of Drinking Water
For the past several years, the Federal-Provincial-Territorial Committee on Drinking Water (CDW) has been assessing the available information on radiological characteristics of drinking water with the intent of revising the existing guidelines for radionuclides in drinking water.
Consultations on Changes to Canada's Radon Guideline
Health Canada, with other members of a Federal Provincial Territorial Radiation Protection Committee working group, have recommended that the current guideline for radon concentrations in dwellings should be reduced.
Regional
Strategic Plan on Aboriginal Health
Regional Discussions on the National Youth and Young Adult Framework for Action on Tobacco Control
Health Canada is working with the Provinces and Territories to develop a Youth and Young Adult Framework on Tobacco Control. This Framework will set out a long-term plan to help address the issue of tobacco use for people under thirty years of age.
Review of
Health Canada's Regulatory Framework for Clinical Trials
Consultations
on the Registration and Disclosure of Clinical Trial
Information
The feedback received will be used to help develop options
for facilitating the registration and disclosure of clinical
trial information.
Regulatory Proposal To Include Warnings in Tobacco Advertisements
Consultation Paper
Available
Report
Reprocessing
of Single Use Medical Devices (SUDs)
Health Canada is currently undertaking consultations
to develop a pan-Canadian strategy to manage the risks
associated with the re-use of single-use medical devices.
Review of Health Canada's Regulatory Framework for Clinical Trials
Revision
of Health Canada's Guidelines for the Safety Assessment
of Novel Foods
The present consultation is intended to solicit comments
on the revised Guidelines for the Safety Assessment of
Novel Foods Derived from Plants and Microorganisms and
on several issues related to the regulation of novel foods
in Canada.
|
| S |
Safety
of Corded Window Covering Products
Health Canada is seeking the views of the Canadian public
on a proposal that, under the Hazardous Products Act, would
put in place legally binding requirements concerning window-
covering products that are advertised, sold, or imported
into Canada.
Selective
COX-2 drugs: Expert Advisory Panel meeting and Public
Forum
The Expert Advisory Panel on selective COX-2 non-steroidal
anti-inflammatory drugs met in Ottawa on June 9 and 10,
2005. The first day consisted of a Public Forum where for
the first time members of the public could present to a
Health Canada expert panel. The second day was held in
camera.
Proposed changes to the Children's Sleepwear: Flammability Requirement Guidelines
The purpose of this consultation is to solicit your comments concerning the revised version of the Children's Sleepwear: Flammability Requirement Guidelines, dated April 2006.
Stakeholder's
Workshop on the Review of Section 29.16 of the New
Substance Notification Regulations (NSNRs)
The purpose of the activity is to engage and seek the
views of interested parties on issues surrounding the effectiveness
of s.29.16 of the NSNRs in protecting human health and
the environment, and possible options to address them.
Strengthening the Evaluation of Real World Drug Safety and Effectiveness
This working conference explores how to enhance the evaluation of the safety and effectiveness of drugs that are on the market. The conference will bring together federal, provincial and territorial officials, health care providers, patient representatives, the pharmaceutical industry and researchers.
|
| T |
Consultations
with Tobacco Cessation Quitline Stakeholders on a Proposed Minimum Dataset for Evaluation
Health Canada is proposing that all Canadian smoking
cessation quitlines collect the same evaluation data for
all callers.
Proposed regulations to prohibit "light" and "mild" descriptors under the Tobacco Act
Due to the federal election, this consultation has been suspended. This site will be updated as further information becomes available.
|
| U |
Update
on proposed Cosmetic Ingredient Labelling Regulations
Health Canada would like to thank everyone who provided
comments on the proposed Cosmetic Ingredient Labelling
Regulations published in Canada Gazette Part I on March
27, 2004.
Additional information on this consultations:
Ingredient
Listing - Proposed Amendment to the Cosmetic Regulations
Proposed
Amendment to the Canadian Cosmetic Regulations
|
| V |
VICH
Consultations
VICH is a trilateral (EU-Japan-USA) program aimed at
harmonizing technical requirements for veterinary product
registration.
Consultations -- Veterinary Drugs Directorate's Animal Tissue Form
Health Canada is seeking your comments on the development
of an Animal Tissue Form that requests information on animal-sourced
material used in the manufacture veterinary drugs.
|
